ATH 33.3% 0.4¢ alterity therapeutics limited

Too bad, PBT2 also failed in presenting any significant...

  1. 516 Posts.
    lightbulb Created with Sketch. 13
    Too bad, PBT2 also failed in presenting any significant difference in Imagine. This is a good comparison. Biogen is moving forward with poor trial results. Prana is stuck with so called good outcome. Poor job by Prana's management!
    Last edited by sgsundy: 04/09/16
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.001(33.3%)
Mkt cap ! $21.28M
Open High Low Value Volume
0.4¢ 0.4¢ 0.3¢ $1.247K 384.2K

Buyers (Bids)

No. Vol. Price($)
39 52935756 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 127950526 19
View Market Depth
Last trade - 16.10pm 14/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.